Clinical observation of cefoperazone sulbactam combined with levofloxacin in the treatment of HAP
ZHOU Jia-jie
DENG Yong-bin
LIU Wei-ling
Abstract：Objective To investigate the clinical efficacy and adverse reactions of the cefoperazone sulbac -tam combined with levofloxacin in the treatment of hospital acquired pneumonia ( HAP) .Methods Forty-two patients with HAP were randomly divided into treatment group and control group , each group with 21 patients.The treatment group was treated with cefoperazone sulbactam combined with levofloxacin and control group was treated with cefopera -zone sulbactam , treatment course was 7~8 d.Results The time of symptoms and sign returned to normal in the treatment group was (48.24 ±7.54)h, that in the control group was (72.36 ±10.24)h (P<0.01);the clinical ef-ficacy of the treatment group was better than the control group ( P<0.05 ) , incidence of adverse reactions was not sta-tistically significant between the two groups ( P>0.05 ) .Conclusion The efficacy of cefoperazone sulbactam com-bined with levofloxacin in the treatment of HAP is significantly better than cefoperazone sulbactam , and this combined use is worthy of promotion .
Keywords：Hospital acquired pneumonia ( HAP)Cefoperazone sulbactamLevofloxacin
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 42-44 )